2019
DOI: 10.1590/0004-282x20180156 View full text |Buy / Rent full text
|
|

Abstract: Transthyretin amyloidosis (ATTR) is characterized by the deposit of mutant or wild-type transthyretin that forms amyloid fibrils, which are extracellularly deposited within tissues and organs. Clinical manifestations of familial amyloid polyneuropathy vary according to the mutation, age at onset and geographical location. This study aimed to describe baseline disease characteristics of Brazilian patients with transthyretin familial amyloid polyneuropathy (ATTR-FAP) enrolled in the Transthyretin Amyloidosis Out… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
2
1
1
1
1
10
0
3

Year Published

2021
2021
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

1
10
0
3
Order By: Relevance
“…Over 30% of patients with the Val30Met variant experienced cardiac symptoms, with or without neurologic symptoms. Cardiac involvement has previously been reported to be present in similar proportions (30-36%) among patients with Val30Met [4,15,16,19] and, as expected, is more frequent among those patients with late-onset disease [4,15]. This reinforces the need for a multidisciplinary approach in endemic areas, independent of the most frequent phenotype of the area.…”
Section: Discussionsupporting
See 1 more Smart Citation
Create an account to read the remaining citation statements from this report. You will also get access to:
  • Search over 1.2b+ citation statments to see what is being said about any topic in the research literature
  • Advanced Search to find publications that support or contrast your research
  • Citation reports and visualizations to easily see what publications are saying about each other
  • Browser extension to see Smart Citations wherever you read research
  • Dashboards to evaluate and keep track of groups of publications
  • Alerts to stay on top of citations as they happen
  • Automated reference checks to make sure you are citing reliable research in your manuscripts
  • 7 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 130,000 students researchers, and industry experts at use scite

See what students are saying

rupbmjkragerfmgwileyiopcupepmcmbcthiemesagefrontiersapsiucrarxivemeralduhksmucshluniversity-of-gavle
“…Over 30% of patients with the Val30Met variant experienced cardiac symptoms, with or without neurologic symptoms. Cardiac involvement has previously been reported to be present in similar proportions (30-36%) among patients with Val30Met [4,15,16,19] and, as expected, is more frequent among those patients with late-onset disease [4,15]. This reinforces the need for a multidisciplinary approach in endemic areas, independent of the most frequent phenotype of the area.…”
Section: Discussionsupporting
“…The neurologic phenotype was the predominant clinical picture of patients with ATTR amyloidosis in Spain, followed by the mixed phenotype. The neurologic phenotype is also predominant in other countries with endemic foci of patients with the Val30Met variant, including Portugal, Sweden, Japan, and Brazil [ 4 , 15 , 16 ]. The cardiac phenotype is more commonly seen in other European countries such as Germany, Denmark, and Italy, where there is a greater distribution of genotypes [ 4 ], and in the United States, where a large proportion of patients have ATTRwt amyloidosis or the Val122Ile (p.Val142Ile) mutation [ 17 ].…”
Section: Discussionmentioning
“…Estudos demonstram que 13% 21 dos pacientes com ICFEP e 25% das necropsias de idosos, 22,23 principalmente do sexo masculino, apresentam depósito de ATTR no coração. 24 Muito mais que uma doença rara, na verdade, a AC é uma condição subdiagnosticada. Dados recentes nos EUA registram o progressivo aumento na prevalência, aumentando de 18 para 55,2 (100.000 pessoas-ano), 25 e fortalecem o conceito da falta do diagnóstico que equivocadamente era considerado como inexistência da doença.…”
Section: Conceitos Geraisunclassified
“…23 Pain and autonomic dysfunction are clinical hallmarks of amyloid neuropathy; although they can occur in CIDP, they do so less frequently and are milder. Pain occurs in 27%-74% of patients with amyloid neuropathy 14,24,25 and approximattely one-third of those with CIDP, 26 whereas autonomic symptoms occur in 65%-94% of patients with amyloid neuropathy 13,24,25,27 and 23% of patients with CIDP. 28 In CIDP, NCS usually show findings indicative of an acquired demyelinating neuropathy and EMG commonly shows diffuse chronic neurogenic changes and active denervation affecting both proximal and distal muscles (polyradiculoneuropathy).…”
Section: Peripheral Nervous Systemmentioning
“…However, the p.Val142Ile (Val122Ile) mutation is relatively common among African Americans (3.5%), 118 and in one study this mutation was found in 10% of African Americans older than 60 years of age with heart failure 119 . Interestingly, patients with p.Val50Met (Val30Met) mutation from Portugal, Brazil, and the southern part of Japan usually present with early‐onset (<50 years) profound autonomic neuropathy and small fiber sensory loss in the second or third decade of life, 120,121,27 whereas patients with same mutation from other regions present with late‐onset (>50 years) pan‐modality sensory loss and mild or no autonomic disturbance 15,122,123 . In ATTRv amyloidosis, the sensitivity of biopsy may vary with genotype and phenotype, but in general, fat aspirate is positive in approximately 45%, 110 lip biopsy in 75%‐91%, 124,125 and skin biopsy in 70% 126 .…”
Section: Brief Overview Of Most Common Systemic Amyloidosis Affecting the Neuromuscular Systemmentioning